Elkedonia

BiotechnologySeedStrasbourg, Franceelkedonia.com

Latest round

Seed

Last raised

Jun 2025

Total raised

$13M

Investors

8

About Elkedonia

Elkodonia SAS, founded in 2025 and headquartered in Strasbourg, France, is dedicated to producing antidepressants emphasizing neuroplasticity.Elkodonia develops innovative antidepressant treatments centered on neuroplasticity. Their flagship product is a neuroplastogen that aims to induce neuroplasticity, thereby reducing side effects common with traditional antidepressants and psychedelics.Elkodonia’s revenue primarily comes from partnerships and collaborations in the pharmaceutical and healthcare sectors, involving business-to-business transactions with healthcare providers and research institutions. Their typical transaction model includes licensing agreements and collaborative research initiatives that integrate their neuroplastogen into clinical trials and treatment protocols. The company is focused on expanding its product offerings and aims to penetrate new markets where mental health disorders are prevalent. They are particularly targeting North America, Europe, and parts of Asia as key regions for growth.

Who invested in Elkedonia

8 investors across 1 round

See all investors in Elkedonia

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jun 11, 2025

    Amount

    $13M

    Investors

    Locked

Questions about Elkedonia

Who invested in Elkedonia?

Elkedonia has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Elkedonia raised?

Elkedonia has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Elkedonia last raise money?

Elkedonia's most recent round on record is a Seed, in Jun 2025.

What does Elkedonia do?

Elkodonia SAS, founded in 2025 and headquartered in Strasbourg, France, is dedicated to producing antidepressants emphasizing neuroplasticity.

Where is Elkedonia headquartered?

Elkedonia is headquartered in Strasbourg, France.

Which VCs invest in companies like Elkedonia?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Elkedonia's stage. Their profiles are linked below.

Raising like Elkedonia? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.